Back to search

Article

Natural killer cells and acute myeloid leukaemia

2013-01-01

Abstract excerpt

Despite successful induction chemotherapy, most patients with acute myeloid leukemia (AML) will relapse. Immune surveillance by T cells or natural killer (NK) cells may play a role in preventing relapse. This thesis examines the potential of NK cells to control AML. Study 1 explored in 248 patients with haematological malignancies from the US National Institutes of Health, the genetic diversity of NK killer immuno...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b0ed1679-51e8-5a70-8614-c5cc1ccbfaf8
DOI
10.25560/18014
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Natural killer cells and acute myeloid leukaemiaDOI 10.25560/18014
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia.Semantic proximity
The role of the killer immunoglobulin-like receptor in haematological malignancies and stem cell transplantationSemantic proximity
HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.Semantic proximity
Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.Semantic proximity
Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association StudySemantic proximity
Genetic mutations and immune microenvironment: unveiling the connection to AML prognosis.Semantic proximity
Adoptive NK cell therapy in AML: progress and challengesSemantic proximity
KIR2DS3 is associated with protection against acute myeloid leukemia.Semantic proximity
Allelic polymorphisms of KIRs and antitumor immunity against chronic myeloid leukemia.Semantic proximity
Human NK receptors: From the molecules to the therapy of high risk leukemiasSemantic proximity
High-Risk Leukemia: Past, Present, and Future Role of NK CellsSemantic proximity
Natural killer cell therapy for hematologic malignancies: successes, challenges, and the futureSemantic proximity
Select a neighboring publication to make it the new centre.